| Pharmaceutical active ingredients: |
| Carbocisteine |
| Available forms, composition and doses of Broncathiol: |
| Solution; Oral; Carbocisteine 100 mg |
| Broncathiol medical category: |
| Human:Cough and cold preparations |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R05CB03 - Carbocisteine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Ortho McNeil PharmaceuticalsTonipharm Laboratoire |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Broncasma | Haemophilus Influenzae Vaccine inactivated; Klebsiella Pneumoniae; Moraxella Catarrhalis; Neisseria Tuberculosis; Pneumococcus; Staphylococcus; Streptococcus Haemolyticus; Streptococcus Viridans | Raul Vieira; Berna; Diethelm; Docpharma; Edward Keller |
| Broncasmin Composto | Guaifenesin; Terbutaline Sulfate | ICN Pharmaceuticals |
| Broncaspin | Guacetisal | Bayer Schering Pharma |
| Broncatar | Bromhexine Hydrochloride; Thiocol | Cazi Quimica Farmaceutica Industria e Comercio |
| Broncatar | Carbocisteine; Promethazine Hydrochloride | Kramer Pharmaceuticals |
| Broncathiol Expectorant | Carbocisteine | Ortho McNeil Pharmaceuticals; Tonipharm Laboratoire |
| Broncelix | Guaifenesin; Oxtriphylline | Pfizer |
| Bronch Eze | Ammonium Chloride; L-Ephedrine Hydrochloride | Pharmavite 1987 |
| Bronchalene Adults | Chlorpheniramine Maleate; Pholcodine | Sanofi-Aventis |
| Bronchalene Children | Chlorpheniramine Maleate; Pholcodine | Sanofi-Aventis |